Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics ; year:2021
Nano select ; (2021)
- Urheber
-
Munjal, Tanya
Dutta, Saikat
- DOI
-
10.1002/nano.202100040
- URN
-
urn:nbn:de:101:1-2021031714014310247434
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Munjal, Tanya
- Dutta, Saikat
Ähnliche Objekte (12)
Catalase‐Based Air‐Cathode for Biocompatible Zinc–Air Battery
Targeting CDK9 for anti-cancer therapeutics
PARP inhibitors: current status and implications for anticancer therapeutics
Akt inhibitors: mechanism of action and implications for anticancer therapeutics
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
Mining the deep Red-Sea brine pool microbial community for anticancer therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics
The role of Wnt signaling pathway in carcinogenesis and implications for anticancer therapeutics
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics
Antioxidant-biocompatible and stable catalase-based gelatin–alginate hydrogel scaffold with thermal wound healing capability: immobilization and delivery approach
Ultra-stable nano-micro bubbles in a biocompatible medium for safe delivery of anti-cancer drugs
Catalase‐Based Air‐Cathode for Biocompatible Zinc–Air Battery
Targeting CDK9 for anti-cancer therapeutics
PARP inhibitors: current status and implications for anticancer therapeutics
Akt inhibitors: mechanism of action and implications for anticancer therapeutics
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
Mining the deep Red-Sea brine pool microbial community for anticancer therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics
The role of Wnt signaling pathway in carcinogenesis and implications for anticancer therapeutics
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics
Antioxidant-biocompatible and stable catalase-based gelatin–alginate hydrogel scaffold with thermal wound healing capability: immobilization and delivery approach
Ultra-stable nano-micro bubbles in a biocompatible medium for safe delivery of anti-cancer drugs
Catalase‐Based Air‐Cathode for Biocompatible Zinc–Air Battery
Targeting CDK9 for anti-cancer therapeutics
PARP inhibitors: current status and implications for anticancer therapeutics
Akt inhibitors: mechanism of action and implications for anticancer therapeutics
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
Mining the deep Red-Sea brine pool microbial community for anticancer therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics
The role of Wnt signaling pathway in carcinogenesis and implications for anticancer therapeutics
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics
Antioxidant-biocompatible and stable catalase-based gelatin–alginate hydrogel scaffold with thermal wound healing capability: immobilization and delivery approach